Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

[Study of immune tolerance induced by HBs antigen specific suppressor T cell--establishment of human suppressor T cell clones].

Isono E, Sekiya H, Nishikawa M, Yamauchi K.

Nihon Rinsho. 1995 Oct;53 Suppl(Pt 2):185-8. Review. Japanese. No abstract available.

PMID:
12442383
2.

Hepatitis B surface antigen-specific CD8-positive T cell clones. Antigen specificity and interleukin-2 production.

Zhang DF, Zarling JM, Wener MH.

Chin Med J (Engl). 1990 Mar;103(3):216-22.

PMID:
1695132
3.

In vitro induction of HBsAg-specific CD8 CD11 human suppressor T cells.

Barnaba V, Ruberti G, Levrero M, Balsano F.

Immunology. 1987 Nov;62(3):431-8.

4.
5.

In vitro anti-HBs antibody synthesis from anti-hepatitis B vaccine recipients.

Barnaba V, Levrero M, Ruberti G, van Dyke A, Perrone A, Musca A, Balsano F.

Clin Exp Immunol. 1987 Nov;70(2):283-8.

6.

Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals.

Chiou SS, Yamauchi K, Nakanishi T, Obata H.

Immunology. 1988 Jul;64(3):545-50.

7.
8.

Effects of mitogens and lymphokines on the regulation of the immune response to HBs antigen in vitro.

Knöller I, Hoffmann UJ, Werchau HH, König W.

Immunology. 1990 Nov;71(3):352-7.

9.

Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.

Gotsman I, Alper R, Klein A, Rabbani E, Engelhardt D, Ilan Y.

Cancer. 2002 Jan 15;94(2):406-14.

11.
12.

Identification of T cell epitopes on hepatitis B surface antigen.

Vento S.

Ann Ist Super Sanita. 1991;27(1):37-40. Review.

PMID:
1720295
13.

Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells.

Kostrzak A, Cervantes Gonzalez M, Guetard D, Nagaraju DB, Wain-Hobson S, Tepfer D, Pniewski T, Sala M.

Vaccine. 2009 Jul 30;27(35):4798-807. doi: 10.1016/j.vaccine.2009.05.092. Epub 2009 Jun 17.

PMID:
19539581
14.

In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.

Cupps TR, Gerin JL, Purcell RH, Goldsmith PK, Fauci AS.

J Clin Invest. 1984 Oct;74(4):1204-13.

15.

Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.

Shimizu Y, Guidotti LG, Fowler P, Chisari FV.

J Immunol. 1998 Nov 1;161(9):4520-9.

16.

[Immunological tolerance to hepatitis B surface antigen].

Yamauchi K.

Nihon Rinsho. 2004 Aug;62 Suppl 8:84-7. Review. Japanese. No abstract available.

PMID:
15453292
18.

Surface markers of cloned human T cells with helper or suppressor activity on pokeweed mitogen-driven B cell differentiation.

Mingari MC, Melioli G, Moretta A, Pantaleo G, Moretta L.

Eur J Immunol. 1982 Oct;12(10):900-3.

PMID:
6217081
19.

Functional implications of hepatitis B surface antigen (HBsAg) in the T cells of chronic HBV carriers.

Nagaraju K, Naik SR, Naik S.

J Viral Hepat. 1997 Jul;4(4):221-30.

PMID:
9278219

Supplemental Content

Support Center